COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07ISX
|
|||
Drug Name |
Thalidomide
|
|||
Synonyms |
thalidomide; Thalomid; Sedoval; 50-35-1; (+/-)-THALIDOMIDE; Psychotablets; Theophilcholine; Psycholiquid; Corronarobetin; Thalinette; Softenon; Shinnibrol; Sedisperil; Polygripan; Pantosediv; Neufatin; Neosedyn; Telargean; Talargan; Profarmil; Neosydyn; Hippuzon; Ectiluran; Valgraine; Sedimide; Sandormin; Quietoplex; Noctosediv; Neurosedym; Neurodyn; Distaval; Bonbrain; Tensival; Talismol; Softenil; Quetimid; Nevrodyn; Neurosedin; Nerosedyn; Glutanon; Gastrinide; Enterosediv; Contergan; Calmorex; Asmad; Thalidomide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2 | [1] | |
Other Indication | Multiple myeloma | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H10N2O4
|
|||
Canonical SMILES |
C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
|
|||
InChI |
1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
|
|||
InChIKey |
UEJJHQNACJXSKW-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 50-35-1
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:74947
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04273529) The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia. U.S. National Institutes of Health. | |||
2 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 021430 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.